PULMONX CORPORATION (LUNG) Operating cash flow 2018–2025
PULMONX CORPORATION (LUNG) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$32.4MFY2025 · since FY2018: -$18.4M → -$32.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$32.4M | -2.7% |
| FY2024 | -$31.5M | +16.1% |
| FY2023 | -$37.6M | +16.6% |
| FY2022 | -$45.1M | -8.9% |
| FY2021 | -$41.4M | -35.1% |
| FY2020 | -$30.6M | -47.5% |
| FY2019 | -$20.8M | -12.9% |
| FY2018 | -$18.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice